Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 4/20 | 0.62 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.45 |
| ▸ | MAOA | P21397 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.39 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.38 |
| ▸ | F7 | P08709 | 1/20 | 0.38 |
| ▸ | LTA4H | P09960 | 1/20 | 0.38 |
| ▸ | F3 | P13726 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | RAD51 | Q06609 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | CTNNB1 | P35222 | 2/20 | 0.36 |
| ▸ | WNT3A | P56704 | 2/20 | 0.36 |
| ▸ | CCNC | P24863 | 1/20 | 0.36 |
| ▸ | CDK8 | P49336 | 1/20 | 0.36 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethoxycarbonyl Group SCHEMBL28658781 | 0.88 | AHR (0.62) | AHRCYP2A6MAOAGPR84CCNC | |
| Ethoxycarbonyl Group SCHEMBL27439208 | 0.84 | CYP2A6 (0.46) | AHRCYP2A6MAOARAB9ANR4A2 | |
| Ethoxycarbonyl Group SCHEMBL27613736 | 0.82 | AHR (0.62) | AHRCYP2A6MAOANPC1NR4A2 | |
| Ethoxycarbonyl Group SCHEMBL27597884 | 0.82 | GAA (0.62) | AHRCYP2A6MAOARAB9ANR4A2 | |
| Ethoxycarbonyl Group SCHEMBL27648955 | 0.82 | CYP2A6 (0.45) | AHRCYP2A6MAOANR4A2F7 | |
| Ethoxycarbonyl Group SCHEMBL27650371 | 0.82 | AHR (0.62) | AHRCYP2A6MAOANR4A2F7 | |
| Ethoxycarbonyl Group SCHEMBL28038686 | 0.82 | CYP2A6 (0.45) | AHRCYP2A6MAOANR4A2F7 | |
| Ethoxycarbonyl Group SCHEMBL27691273 | 0.82 | KIF11 (0.44) | AHRCYP2A6MAOACTNNB1WNT3A | |
| Ethoxycarbonyl Group SCHEMBL28672702 | 0.81 | MAOA (0.52) | CYP2A6MAOANPC1RAB9ALTA4H | |
| Ethoxycarbonyl Group SCHEMBL27597895 | 0.80 | CYP2A6 (0.54) | AHRCYP2A6MAOANR4A2F7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104961732-A | Pyrazole Compounds as CRTH2 Antagonists | BOEHRINGER INGELHEIM INT | 2015-10-07 | — | — | CN | disclosed |
| CN-103339125-B | Pyrazole compounds as CRTH2 antagonists | BOEHRINGER INGELHEIM INT | 2015-07-15 | — | — | CN | disclosed |
| CN-104628705-A | Pyrazole compounds as CRTH2 antagonists | BOEHRINGER INGELHEIM INT | 2015-05-20 | — | — | CN | disclosed |
| CN-104402795-A | Synthetic method of substituted indol-2-formic acid | UNIV CHINA AGRICULTURAL | 2015-03-11 | — | — | CN | disclosed |
| CN-103339125-A | Pyrazole compounds as CRTH2 antagonists | BOEHRINGER INGELHEIM INT | 2013-10-02 | — | — | CN | disclosed |
| CN-101379041-B | Tricyclic N-heteroaryl-carboxamide derivatives containing a benzimidazole structural element, their preparation and their therapeutic use | SANOFI AVENTIS | 2012-08-29 | — | — | CN | disclosed |
| CN-101010297-B | N- (1H-indolyl) -1H-indole-2-carboxamide derivatives, their preparation and their pharmaceutical use | SANOFI AVENTIS | 2011-07-27 | — | — | CN | disclosed |
| CN-101115718-B | N- (heteroaryl) -1H-indole-2-carboxamide derivatives and their use for the preparation of a medicament for the prevention or treatment of diseases related to the capsaicin TRPV1 receptor | SANOFI AVENTIS | 2011-06-08 | — | — | CN | disclosed |
| CN-102007100-A | Compounds and compositions as modulators of GPR119 activity | IRM LLC | 2011-04-06 | — | — | CN | disclosed |
| CN-101379041-A | Tricyclic N-heteroaryl-amide derivatives containing benzimidazole structural units, their preparation and their therapeutic use | SANOFI AVENTIS (FR) | 2009-03-04 | — | — | CN | disclosed |
| CN-101115718-A | N- (heteroaryl) -1H-indole-2-carboxamide derivatives and their use as vanilloid TRPV1 receptor ligands | SANOFI AVENTIS (FR) | 2008-01-30 | — | — | CN | disclosed |
| CN-101010297-A | N- (1H-indolyl) -1H-indole-2-carboxamide derivatives, their preparation and their pharmaceutical use | SANOFI AVENTIS (FR) | 2007-08-01 | — | — | CN | disclosed |
| CN-1197860-C | FAB I inhibitors | SMITHKLINE BEECHAM CORP (CA) | 2005-04-20 | — | — | CN | disclosed |
| CN-1378542-A | Antigen binding fragment I inhibitors | SMITHKLINE BEECHAM CORP (US) | 2002-11-06 | — | — | CN | disclosed |
| CN-1061341-C | 1-amino-ethylindole-derivatives | HOFFMANN LA ROCHE (CH) | 2001-01-31 | — | — | CN | disclosed |
| CN-1118347-A | Benzotoudened 5-ringneterocycl, preparation and phamaceutical and diagnostic use of same | HOECHST AG (DE) | 1996-03-13 | — | — | CN | disclosed |
| CN-1105988-A | 1-amino-ethylindole-derivatives | HOFFMANN LA ROCHE (CH) | 1995-08-02 | — | — | CN | disclosed |
| CN-1054600-A | New anticholinesterase three ring-cyclammonium | PFIZER (US) | 1991-09-18 | — | — | CN | disclosed |